Prevalence of rheumatoid arthritis in Germany based on health insurance data. Regional differences and first results of the PROCLAIR study

被引:42
作者
Hense, S. [1 ,2 ]
Ramos, A. Luque [1 ]
Callhoff, J. [3 ]
Albrecht, K. [3 ]
Zink, A. [3 ,4 ]
Hoffmann, F. [1 ]
机构
[1] Carl von Ossietzky Univ Oldenburg, Dept Versorgungsforsch, Fak Med & Gesundheitswissensch, Ammerlander Heerstr 140, D-26111 Oldenburg, Germany
[2] Robert Koch Inst, Abt Epidemiol & Gesundheitsmonitoring, Berlin, Germany
[3] Deutsch Rheumaforschungszentrum Berlin, Programmbereich Epidemiol, Berlin, Germany
[4] Charite, Klin Schwerpunkt Rheumatol & Klin Immunol, Berlin, Germany
来源
ZEITSCHRIFT FUR RHEUMATOLOGIE | 2016年 / 75卷 / 08期
关键词
Rheumatoid arthritis; Epidemiology; Secondary data; Health services research; Healthcare insurance data; VALIDATION; SMOKING; RISK;
D O I
10.1007/s00393-016-0088-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Rheumatoid arthritis (RA) is the most common chronic inflammatory joint disease with a prevalence of up to 1 % in the adult population. This study describes the prevalence of RA diagnoses in outpatient health insurance claims data, based on different case definitions and stratified by age, sex and region of residence. Based on data from a nationwide statutory health insurance fund (BARMER GEK) from the year 2013, a cross-sectional study of insurants aged 18 years or older was conducted. The following case definitions were applied: A) a diagnosis of seropositive rheumatoid arthritis (M05) or other rheumatoid arthritis (M06) according to the international classification of diseases 10 German modification (ICD-10-GM) in at least two quarterly periods of the year 2013, B) case definition A plus determination of CaEuroreactive protein (CRP) or erythrocyte sedimentation rate (ESR) at least once, C) case definition B plus specific drug therapy and D) case definition A plus treatment by a rheumatologist. Raw as well as age and sex-standardized prevalences were calculated and stratified according to the federal state. The study population consisted of 7,155,315 insurants of whom 60.2 % were female. Overall, RA prevalences for the respective case definitions were 1.62 % (A), 1.11 % (B), 0.94 % (C) and 0.64 % (D). When standardized to the German population the prevalences were 1.38 % (A), 0.95 % (B), 0.81 % (C) and 0.55 % (D). The proportion of women was approximately 80 % for all case definitions. Prevalences increased with age, peaking in the age group 70-79 years old and showing the highest values in eastern and the lowest in southern Germany for raw as well as standardized measures. Regional differences in the prevalence of RA diagnoses in health insurance claims data were observed independent of age, sex and case definition. The expected prevalence according to the results of international studies was best achieved when case definitions with CRP or ESR were considered.
引用
收藏
页码:819 / 826
页数:8
相关论文
共 42 条
  • [1] Prevalence of Rheumatoid Arthritis in Germany: Analysis of Longitudinal Data of Statutory Health Insurance
    Kienitz, Carsten
    Grellmann, Claudia
    Hapfelmeier, Jana
    GESUNDHEITSWESEN, 2021, 83 (05) : 367 - 373
  • [2] Regional Differences in Opioid Prescribing in Germany - Results of an Analysis of Health Insurance Data of 57 Million Adult People
    Jobski, Kathrin
    Doerks, Michael
    Bantel, Carsten
    Hoffmann, Falk
    JOURNAL OF PAIN RESEARCH, 2020, 13 : 2483 - 2492
  • [3] Regional and gender differences in population-based oral health insurance data
    Stamm, Tanja
    Ritschl, Valentin
    Platzer, Alexander
    Omara, Maisa
    Mosor, Erika
    Reichardt, Berthold
    Schmitl, Lina
    Behanova, Martina
    Bekes, Katrin
    CLINICAL ORAL INVESTIGATIONS, 2020, 24 (07) : 2331 - 2339
  • [4] Regional and gender differences in population-based oral health insurance data
    Tanja Stamm
    Valentin Ritschl
    Alexander Platzer
    Maisa Omara
    Erika Mosor
    Berthold Reichardt
    Lina Schmitl
    Martina Behanova
    Katrin Bekes
    Clinical Oral Investigations, 2020, 24 : 2331 - 2339
  • [5] Real-world treatment persistence in patients with rheumatoid arthritis initiating DMARDs in Germany-a health insurance claims data analysis
    Fiehn, Christoph
    Zinke, Silke
    Haas, Jennifer S.
    Meise, Dominic
    Theil, Julia
    Gurrath, Margot
    Orzechowski, Hans-Dieter
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2023, 82 (09): : 739 - 753
  • [6] High prevalence of cardiovascular comorbidities in patients with rheumatoid arthritis from a population-based cross-sectional study of a Japanese health insurance database
    Sakai, Ryoko
    Hirano, Fumio
    Kihara, Mari
    Yokoyama, Waka
    Yamazaki, Hayato
    Harada, Sayoko
    Nanki, Toshihiro
    Koike, Ryuji
    Miyasaka, Nobuyuki
    Harigai, Masayoshi
    MODERN RHEUMATOLOGY, 2016, 26 (04) : 522 - 528
  • [7] Prevalence of Cancer in Rheumatoid Arthritis: Epidemiological Study Based on the National Health and Nutrition Examination Survey (NHANES)
    Bhandari, Binita
    Basyal, Bikash
    Sarao, Manbeer S.
    Nookala, Vinod
    Thein, Yamin
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (04)
  • [8] Suboptimal management of rheumatoid arthritis in France: a real-world study based on data from the French National Health Data System
    Gaujoux-Viala, Cecile
    Bergmann, Jean-Francois
    Goguillot, Melanie
    Melaine, Asma
    Guerin, Marie
    Edouard, Alban
    Benard, Steve
    Fautrel, Bruno
    RMD OPEN, 2023, 9 (04):
  • [9] Estimates of the prevalence of and current treatment practices for rheumatoid arthritis in Japan using reimbursement data from health insurance societies and the IORRA cohort (I)
    Yamanaka, Hisashi
    Sugiyama, Naonobu
    Inoue, Eisuke
    Taniguchi, Atsuo
    Momohara, Shigeki
    MODERN RHEUMATOLOGY, 2014, 24 (01) : 33 - 40
  • [10] Regional differences regarding risk of developing rheumatoid arthritis in Stockholm County, Sweden: results from the Swedish Epidemiological Investigation of Rheumatoid Arthritis (EIRA) study
    Kallberg, H.
    Vieira, V.
    Holmqvist, M.
    Hart, J. E.
    Costenbader, K. H.
    Bengtsson, C.
    Klareskog, L.
    Karlson, E. W.
    Alfredsson, L.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2013, 42 (05) : 337 - 343